Disposition of 5000 shares by Gregory Russotti of Century Therapeutics at 3.0979 subject to Rule 16b-3

Read at macroaxis.com

Published over six months ago View all stories for Century Therapeutics | Century Therapeutics Hype Analysis

Disposition of 5000 common stock at 3.0979 of Century Therapeutics by Gregory Russotti on 22nd of April 2024. This event was filed by Century Therapeutics with SEC on 2024-04-22. Statement of changes in beneficial ownership - SEC Form 4

We analyze Century Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Century Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Century Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Century Therapeutics stock to make a market-neutral strategy. Peer analysis of Century Therapeutics could also be used in its relative valuation, which is a method of valuing Century Therapeutics by comparing valuation metrics with similar companies.

When running Century Therapeutics' price analysis, check to measure Century Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Century Therapeutics is operating at the current time. Most of Century Therapeutics' value examination focuses on studying past and present price action to predict the probability of Century Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Century Therapeutics' price. Additionally, you may evaluate how the addition of Century Therapeutics to your portfolios can decrease your overall portfolio volatility.